Regarding the question of linked liver injuries and liver failure about the Lianhua Qingjuan, China responded on Sunday (December 18) in China.The safety and effectiveness of the flowers of the flowers clearing the plague.

According to the First Financial Report, with the announcement of Ling Pharmaceutical, the statistics of the National Adverse Reaction Monitoring Center showed that as of now, the incidence of adverse reactions is one of the 100,000.According to the criteria recommended by the International Medical Science Organization Committee, the incidence of adverse reactions is a very rare level, and there is no adverse reactions related to liver and kidney dysfunction related to Lianhua Qingjuan.

The company also announced that the results of acute toxicity experiments showed that even the dosage of the dosage of the rats of the flowers of the flowers reached 18g/kg, which was equivalent to 453 times the clinical dosage of the human body.In the study of toxic research, dogs and rats are continuously administered around. The dosage is equivalent to 24 times and 145 times that of human clinical dosage. No drug -related toxic response is found.

In terms of the analysis of the gathered, the company announced that a fighter analysis of 217 clinical research adverse reactions from the launch of the flowers of the flowers from the market to February 2021 involves the treatment of influenza, respiratory infection, and respiratory tract infection, and respiratory tract infection, and the respiratory tract infection, and the respiratory tract infection, and the respiratory tract infection, and the respiratory tract infection.The clinical study of diseases such as pneumonia and new crown pneumonia showed that the incidence of adverse reactions in the total adverse reaction of the conventional drug group compared with the conventional drug group was seen, and no liver and kidney dysfunction related to the Lianhua Qingjuan was seen.

Lianhua Qing Plague Capsule is the leading product of Ling Pharmaceutical, which is mainly used for the treatment of colds, flu, and crown disease -related diseases.Recently, Lianhua Qing Plague is in short supply.The reporter checked multiple e -commerce platforms, showing that the medicine was still out of stock.